Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 06 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 53.80 and Closed at: 53.09, which is -1.07% of previous session's close. It moved within a range of 52.45 and 53.80
The session was a Bearish session with an average volume of 3776800, which is -0.68% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 6 days back on mid term averages
Support for tomorrow is 52.1 and resistance for tomorrow is 53.45
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 52.43, 51.76 resistance for tomorrow's hourly charts is 53.78, 54.46
10 Day SMA for Glaxosmithkline Plc (GSK) is 52.16 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 51.97 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 51.45 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 54.04 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 50.72 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 51.97 and 200 DMA is at 50.72, while 50 DMA and 100 DMA are at 51.45 and 54.04 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 51.97 and 20 EMA is at 52.02
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Mon Jul | 53.09 | 51.97 | 52.02 |
| 02 Thu Jul | 53.66 | 51.88 | 51.91 |
| 01 Wed Jul | 51.30 | 51.68 | 51.73 |
| 30 Tue Jun | 52.42 | 51.56 | 51.78 |
| 29 Mon Jun | 52.81 | 51.41 | 51.71 |
| 26 Fri Jun | 52.50 | 51.29 | 51.59 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 51.45 and 50 EMA is at 52.17
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Mon Jul | 53.09 | 51.45 | 52.17 |
| 02 Thu Jul | 53.66 | 51.5 | 52.13 |
| 01 Wed Jul | 51.30 | 51.54 | 52.07 |
| 30 Tue Jun | 52.42 | 51.64 | 52.1 |
| 29 Mon Jun | 52.81 | 51.74 | 52.09 |
| 26 Fri Jun | 52.50 | 51.85 | 52.06 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 54.04 and 100 EMA is at 52.2
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Mon Jul | 53.09 | 54.04 | 52.2 |
| 02 Thu Jul | 53.66 | 54.1 | 52.18 |
| 01 Wed Jul | 51.30 | 54.15 | 52.15 |
| 30 Tue Jun | 52.42 | 54.24 | 52.17 |
| 29 Mon Jun | 52.81 | 54.31 | 52.16 |
| 26 Fri Jun | 52.50 | 54.35 | 52.15 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 50.72 and 200 EMA is at 50.06
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Mon Jul | 53.09 | 50.72 | 50.06 |
| 02 Thu Jul | 53.66 | 50.65 | 50.03 |
| 01 Wed Jul | 51.30 | 50.59 | 49.99 |
| 30 Tue Jun | 52.42 | 50.54 | 49.98 |
| 29 Mon Jun | 52.81 | 50.48 | 49.96 |
| 26 Fri Jun | 52.50 | 50.42 | 49.93 |
Unitedhealth Group has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Unitedhealth Group, about 1.55% more returns!
Takeda Pharmaceutical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 5.22% more returns!
Glaxosmithkline Plc has performed better than Steris Plc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Smith Nephew in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Avanos Medical in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Cardinal Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Cardinal Health, about 12.41% more returns!
Chemed Corp has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Chemed Corp, about 5.76% more returns!
Centene Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Centene Corporation, about 2.92% more returns!
Charles River has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Charles River, about 24.57% more returns!
Cvs Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Cvs Health, about 3.36% more returns!
Quest Diagnostics has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Quest Diagnostics, about 3.52% more returns!
Elanco Animal has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Elanco Animal, about 3.3% more returns!
Edwards Lifesciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 7.68% more returns!
Glaukos Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Glaukos Corporation, about 15.91% more returns!
Haemonetics Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 2.2% more returns!
Humana Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Humana Inc, about 9.24% more returns!
Prestige Consumer has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Prestige Consumer, about 0.51% more returns!
Glaxosmithkline Plc has performed better than Pfizer Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 52.23 and Glaxosmithkline Plc GSK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
